C4 Therapeutics, Inc. Employee Count
The employee counts C4 Therapeutics, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 104; Filing 2026-02-26; Lease expense per employee $103,451.92.
- 2024-12-31: Employees (as filed) 110; Filing 2025-02-27; Lease expense per employee $84,063.64.
- 2023-12-31: Employees (as filed) 145; Filing 2024-02-22; Lease expense per employee $65,048.28.
- 2022-12-31: Employees (as filed) 146; Filing 2023-02-23; Lease expense per employee $72,438.36.
- Available history
- 2021-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 104 full-time | 2026-02-26 | $103,451.92 total lease cost |
| 2024-12-31 | 110 full-time | 2025-02-27 | $84,063.64 total lease cost |
| 2023-12-31 | 145 full-time | 2024-02-22 | $65,048.28 total lease cost |
| 2022-12-31 | 146 full-time | 2023-02-23 | $72,438.36 total lease cost |
| 2021-12-31 | 121 full-time | 2022-02-24 | $29,280.99 total lease cost |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |